The Role of Central Serotonergic and Adrenergic Systems in the Effectiveness of DNIC (Diffuse Noxious Inhibitory Control
This trial is active, not recruiting.
|Sponsor||Rambam Health Care Campus|
|Start date||August 2007|
|End date||August 2009|
|Trial size||100 participants|
|Trial identifier||NCT00660751, DNIC01CTIL|
The role of central serotonergic and adrenergic systems in the effectiveness of DNIC (Diffuse Noxious Inhibitory Control) will be tested before and after taking Duloxetine and Placebo in a double blind study.
|Intervention model||single group assignment|
|Masking||double blind (subject, investigator, outcomes assessor)|
|Primary purpose||basic science|
level of DNIC
time frame: 1 week
Male or female participants from 18 years up to 80 years old.
Inclusion Criteria: - Healthy volunteers - age 18-80 - no chronic disease Exclusion Criteria: - Subjects who suffer from chronic pain / pain syndrome - use of anti-depressant or anti-psychotic drugs - food/ drugs sensitivity - breast feeding
|Official title||The Role of Central Serotonergic and Adrenergic Systems in the Effectiveness of DNIC (Diffuse Noxious Inhibitory Control|
|Principal investigator||Prof. David Yarnitsky|
Call for more information